Cormorant Asset Management’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,800,000
| Closed | -$42.5M | – | 64 |
|
|
2023
Q4 | $42.5M | Sell |
1,800,000
-2,050,000
| -53% | -$48.4M | 2.03% | 13 |
|
|
2023
Q3 | $57.4M | Buy |
3,850,000
+50,000
| +1% | +$746K | 3.35% | 6 |
|
|
2023
Q2 | $41.6M | Buy |
3,800,000
+2,528,571
| +199% | +$27.7M | 2.33% | 8 |
|
|
2023
Q1 | $11.1M | Buy |
+1,271,429
| New | +$11.1M | 0.73% | 35 |
|
|
2017
Q4 | – | Sell |
-500,000
| Closed | -$4.03M | – | 54 |
|
|
2017
Q3 | $4.03M | Buy |
+500,000
| New | +$4.03M | 0.71% | 37 |
|